Independent
Tenure on this board
0.0 yrs
Meeting calendar
EMBC · Annual meeting · Wednesday, February 11, 2026
Embecta Corp
7 nominees · 4 ballot items.
The four proposals on the agenda for Embecta's 2026 Annual Meeting comprise (1) election of seven director nominees for a one-year term with the board recommending voters vote for all nominees, (2) ratification of Ernst & Young LLP as Embecta’s independent registered public accounting firm for fiscal 2026, (3) a non-binding advisory vote to approve named executive officer compensation, and (4) approval of an amendment to the Embecta 2022 Employee and Director Equity-Based Compensation Plan to increase the share reserve by 2,430,000 shares.
Market cap
$208M
1Y TSR
-72.3%
Board grade
C-
Record date
Dec 15, 2025
Filing
DEF 14A
Meeting concluded · Feb 11, 2026
Follow how the vote landed and what changed on Embecta Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot4
- 1
Election of directors
ManagementBoard: FORElection of seven nominees named in the attached proxy statement for a one-year term.
- 2
Ratification of selection of independent registered public accounting firm
ManagementBoard: FORRatification of the Audit Committee’s selection of Ernst & Young LLP as Embecta’s independent registered public accounting firm for fiscal year 2026.
- 3
Advisory vote to approve named executive officer compensation
ManagementBoard: FORAdvisory vote on the compensation of Embecta’s named executive officers as disclosed in the proxy statement.
- 4
Approval of an amendment to the Embecta 2022 Employee and Director Equity-Based Compensation Plan
ManagementBoard: FORApproval of an amendment to increase the number of Embecta common shares authorized for issuance under the 2022 Plan by 2,430,000 shares.
Director elections
Nominees on the ballot7
Independent
Tenure on this board
4.4 yrs
Also a director at
Biomarin Pharmaceutical Inc (BMRN)Seaport Therapeutics Inc (SPTX)
Not independent
Tenure on this board
4.3 yrs
Also a director at
Zimmer Biomet Holdings Inc (ZBH)
Independent
Tenure on this board
4.3 yrs
Also a director at
Myomo Inc (MYO)Nordson Corp (NDSN)
Independent
Tenure on this board
4.3 yrs
Also a director at
Haemonetics Corp (HAE)
Independent
Tenure on this board
4.3 yrs
Also a director at
Atricure Inc (ATRC)Outset Medical Inc (OM)
Independent
Tenure on this board
4.3 yrs
Also a director at
Encompass Health Corp (EHC)
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 10.9% | 6,452,167 | $57M |
| 2 | YACKTMAN ASSET MANAGEMENT LP | 6.2% | 3,671,877 | $32M |
| 3 | River Road Asset Management, LLC | 5.8% | 3,449,502 | $30M |
| 4 | AMERICAN CENTURY COMPANIES INC | 5.8% | 3,439,512 | $30M |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 4.3% | 2,563,951 | $23M |
| 6 | STATE STREET CORP | 4.3% | 2,545,973 | $23M |
| 7 | DEERFIELD MANAGEMENT COMPANY, L.P. | 4.3% | 2,534,961 | $22M |
| 8 | Jefferies Financial Group Inc. | 4.0% | 2,355,162 | $21M |
| 9 | Sio Capital Management, LLC | 3.1% | 1,847,850 | $16M |
| 10 | BlackRock, Inc. | 3.0% | 1,769,610 | $16M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Embecta Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Artiva Biotherapeutics IncARTV
Annual meeting·Sep 8, 2026·$286M
Simulations Plus IncSLP
Special meeting·Aug 27, 2026·$371M
Ocugen IncOCGN
Special meeting·Sep 21, 2026·$421M
Replimune Group IncREPL
Annual meeting·Sep 15, 2026·$1.1B
Kestra Medical Technologies LtdKMTS
Annual meeting·Sep 9, 2026·$1.5B
Anaptysbio IncANAB
Annual meeting·Aug 11, 2026·$1.6B
Reference
Frequently asked questions
- When is the Embecta Corp 2026 annual meeting?
- Embecta Corp (EMBC) holds its 2026 annual shareholder meeting on Wednesday, February 11, 2026.
- What is the record date for the Embecta Corp 2026 meeting?
- The record date for the Embecta Corp 2026 meeting is Monday, December 15, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Embecta Corp's 2026 meeting?
- The board is presenting 7 director nominees at the Embecta Corp 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Embecta Corp 2026 meeting?
- Shareholders will vote on 4 proposals at the Embecta Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.